Melanocytic nevi
Chapter 2:Neoplasms
ICD-10 D22 is a billable code used to indicate a diagnosis of melanocytic nevi.
Melanocytic nevi, commonly known as moles, are benign tumors of melanocytes, the cells responsible for producing melanin, the pigment that gives skin its color. These nevi can appear anywhere on the skin and vary in size, shape, and color. They are typically classified as either congenital (present at birth) or acquired (developing over time). While most melanocytic nevi are harmless, some may undergo changes that could indicate malignancy, necessitating careful monitoring. Clinically, these lesions are often asymptomatic, but patients may seek evaluation for cosmetic reasons or due to changes in appearance. Management typically involves observation, but excision may be warranted if there are concerns about atypical features or changes in the nevus. Follow-up care is essential to monitor for any changes that may suggest malignant transformation, particularly in patients with multiple nevi or a family history of skin cancer. Regular skin examinations and patient education on self-monitoring are crucial components of management.
Detailed descriptions of the nevus, including size, color, and any changes over time.
Evaluation of new or changing moles, management of multiple nevi, and cosmetic removal.
Ensure clear documentation of any atypical features that may necessitate further evaluation.
Basic descriptions of nevi and any patient-reported changes.
Routine skin checks, referrals to dermatology for suspicious lesions.
Document patient education on self-monitoring for changes in nevi.
Used when a benign nevus is excised for cosmetic reasons or due to changes.
Document the size, location, and reason for excision.
Dermatologists should ensure clear documentation of the lesion's characteristics.
D22 is specifically for benign melanocytic nevi, while D23 is used for other benign neoplasms of the skin that do not fit the criteria for D22. Accurate documentation is essential to determine the correct code.
